Cargando…
An exciting RXRA mutant revives interest in retinoids for acute myeloid leukemia
Autores principales: | Qiu, Fang, De The, Hugues |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804556/ https://www.ncbi.nlm.nih.gov/pubmed/34134475 http://dx.doi.org/10.3324/haematol.2021.279152 |
Ejemplares similares
-
Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo
por: Rajamani, Bharathi M., et al.
Publicado: (2023) -
Retinoid Differentiation Therapy for Common Types of Acute Myeloid Leukemia
por: Brown, Geoffrey, et al.
Publicado: (2012) -
RXRA DT448/9PP generates a dominant active variant capable of inducing maturation in acute myeloid leukemia cells
por: di Martino, Orsola, et al.
Publicado: (2021) -
Disrupting autophagy in FLT3-mutant acute myeloid leukemia
por: Grant, Steven
Publicado: (2022) -
Low-intensity induction in acute myeloid leukemia. Always in the patients' best interest?
por: Atallah, Ehab
Publicado: (2022)